Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.
-
Upload
stella-jordan -
Category
Documents
-
view
224 -
download
0
Transcript of Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.
![Page 1: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/1.jpg)
Cardiovascular Laboratory Medicine
Brenda Beckett, PA-C
![Page 2: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/2.jpg)
Specimen Collection
Fasting– nothing to eat or drink for 10-12 hours– can have H2O and medication
![Page 3: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/3.jpg)
Specific Tests to System
- Screening tests: Lipids, CRP, Homocysteine
- Identifying disease: BNP, cardiac enzymes
![Page 4: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/4.jpg)
CV Screening Tests-Lipids
FASTING SPECIMEN Total Cholesterol HDL Triglycerides LDL - calculated or direct
![Page 5: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/5.jpg)
Newest Guidelines
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), or ATP III
![Page 6: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/6.jpg)
Screening
Can screen with Total Cholesterol, if >200, perform complete lipid profile
Screening should be performed on adults every 5 years
Normal Ranges are not determined as other lab tests - national standard
![Page 7: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/7.jpg)
Total Cholesterol Levels
< 200 mg/dl
200-239 mg/dl
>= 240 mg/dl
Desirable, low risk for heart disease
Borderline high
High Cholesterol. In this range, a person has twice the risk of heart disease as person with <200 mg/dl
![Page 8: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/8.jpg)
HDL-Cholesterol Levels
< 40 mg/dl
40-59 mg/dl
>=60 mg/dl
A major risk factor for heart disease
The higher the HDL, the better
Considered protective against heart disease
![Page 9: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/9.jpg)
LDL-Cholesterol Levels
< 100 mg/dl
100-129 mg/dl
130-159 mg/dl
160-189 mg/dl
>=190 mg/dl
Optimal
Near Optimal/ Above Optimal
Borderline High
High
Very High
![Page 10: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/10.jpg)
LDL-Cholesterol Levels
Target levels of LDL are adjusted if someone has existing risk factors for cardiovascular disease.
Tables, p 118 Wallach
![Page 11: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/11.jpg)
Triglyceride Levels
< 150 mg/dl
150-199 mg/dl
200-499 mg/dl
>=500 mg/dl
Normal
Borderline High
High
Very high
![Page 12: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/12.jpg)
Determining CV Risk
Identify presence of clinical atherosclerotic disease that confers high risk for coronary heart disease (CHD) events (CHD risk equivalent):
• Clinical CHD• Symptomatic carotid artery disease• Peripheral arterial disease• Abdominal aortic aneurysm
Note: Diabetes is regarded as a CHD risk equivalent.
![Page 13: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/13.jpg)
Determining CV Risk, cont
Determine presence of major risk factors (other than LDL):
• Cigarette smoking• Hypertension (BP 140/90 mmHg or on antihypertensive
medication)• Low HDL cholesterol (<40 mg/dl)* HDL >60 counts as a
"negative" risk factor and removes one risk factor from count.• Family history of premature CHD (CHD in male first
degree relative <55 years; CHD in female first degree relative <65 years)
• Age (men 45 years; women 55 years)
![Page 14: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/14.jpg)
Determining CV Risk, cont
Determine risk category:
• Establish LDL goal of therapy
• Determine need for therapeutic lifestyle changes (TLC)
• Determine level for drug consideration
![Page 15: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/15.jpg)
Determining CV Risk, cont
LDL Cholesterol Goals for TLC and Drug Therapy in Risk Categories:
CHD risk equivalent <100 mg/dl
2+ risks <130 mg/dl
0-1 risk <160 mg/dl
![Page 16: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/16.jpg)
Determining CV Risk, cont
Initiate therapeutic lifestyle changes (TLC) if LDL is above goal.
– Diet, weight management, physical activity.
Consider adding drug therapy if LDL continues to exceed goal.
http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance.htm
![Page 17: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/17.jpg)
Other Screening Tests
Homocysteine Amino acid in the blood. Increased homocysteine related to increased
risk of coronary heart disease, stroke and peripheral vascular disease.
Strongly influenced by diet - folic acid and vitamins B6 and B12 as well as by genetic factors
![Page 18: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/18.jpg)
Other Screening Tests
CRP (Cardio or ultrasensitive) Traditionally used to diagnose and
monitor acute inflammatory states Mild CRP elevation (within the normal,
non-acute-phase range) has recently emerged as a valuable marker of cardiovascular risk.
Measured twice, 2 weeks apart.
![Page 19: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/19.jpg)
Diagnosis of AMI
A number of laboratory tests are available.
None is completely sensitive and specific for MI, particularly in the hours following onset of symptoms.
Timing is important, as are correlation with patient symptoms, ECGs, and angiographic studies.
![Page 20: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/20.jpg)
Diagnosis of AMI
CK, Total (Creatine Kinase): Simple, quick test. Not specific for MI. Three fractions: MM (skeletal muscle), MB (cardiac muscle), BB (brain tissue).
CKMB: Specific for cardiac injury. Rises 2-8 hrs after injury, returns to normal in 2-3 days. Serial testing every 4 hrs can provide a pattern.
![Page 21: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/21.jpg)
Diagnosis of AMI
CKMB isoforms: – 1 and 2. Performed by electrophoresis. – Ratio of 2 to 1 can determine early cardiac
injury. – Labor intensive and not routinely used.
![Page 22: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/22.jpg)
Diagnosis of AMI
Troponins I and T: Structural components of cardiac muscle. Released with injury. More specific than CKMB.
Rise within 3-12 hours, remain elevated for up to 2 weeks. Difficult to diagnose reinfarction, helpful with old MI.
![Page 23: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/23.jpg)
Diagnosis of AMI
Myoglobin: Protein in skeletal and cardiac muscle. Sensitive but not specific. Rises early
LDH: Not used routinely. Need to measure isoenzymes.
![Page 24: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/24.jpg)
![Page 25: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/25.jpg)
![Page 26: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/26.jpg)
On the horizon
h-FABP: Heart Fatty-Acid Binding Protein Early detection (as early as 20 min) Small cytosolic protein abundant in the heart Detects MI and reperfusion Renal clearance in few hours
![Page 27: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/27.jpg)
![Page 28: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/28.jpg)
Diagnosis of AMI - ACC guidelines
Typical rise and fall of biochemical markers (CKMB and Troponin) and at least one of the following:– Ischemic symptoms– New pathological Q waves on ECG– Ischemic ECG changes (ST elevation or
depression)– Coronary artery intervention
![Page 29: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/29.jpg)
Case Study #1
30 yo male, admitted with CC of severe squeezing pain, lasted 10 min. Began after dinner. Radiated to L shoulder and jaw, assoc with palpitations, SOB. Similar episode 1 mo ago. Smokes 2ppd cigarettes.
FH: grandfather, father, sister all died from heart attacks at early age.
![Page 30: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/30.jpg)
Case Study #1
PE: Pale, restless young man in severe distress due to 8/10 chest pain. Pain subsided after given nitro. BP 140/85, HR 90, RR 17, T 98F. Physical exam unremarkable.
ECG: Elevated ST segments in precordial leads.
Differential Diagnosis?
![Page 31: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/31.jpg)
Case Study #1
What labs to order to confirm diagnosis?
![Page 32: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/32.jpg)
Case Study #1
What further testing do you want to order?
![Page 33: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/33.jpg)
Case Study #1
Diagnosis?:
![Page 34: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/34.jpg)
CHF
BNP -B-type (brain) natriuretic peptide Useful for diagnosing CHF, predicting
morbidity and mortality, and maximizing therapy in these patients
First isolated from brain tissue, but is synthesized primarily in the ventricles of the heart.
NT-proBNP (isomer of BNP) testing has the same clinical utility as BNP
![Page 35: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/35.jpg)
BNP
Increases glomerular filtration rate Decreases sodium retention, and
inhibits renin and aldosterone secretion. Marker of cardiac dysfunction that
correlates with the severity of symptomatic and asymptomatic left ventricular hypertrophy and CHF
![Page 36: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/36.jpg)
CHF
Other laboratory findings in CHF: Anemia Renal function tests: may have prerenal
azotemia Lytes: hypokalemia, hyperkalemia,
hyponatremia
![Page 37: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/37.jpg)
Bacterial Endocarditis
Blood culture: Proper collection, multiple collections
Pathogens: Strep viridans, S. aureus, Strep pneumoniae, enterococcus.
IV drug abusers: S. aureus
![Page 38: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/38.jpg)
Hypertension
In primary hypertension, lab results can be normal.
Abnormalities may include: UA: hematuria, proteinuria, casts Lytes: potassium abnormalities FBS: screen for diabetes, metabolic
syndrome. Lipids: screen for atherosclerosis risk
![Page 39: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/39.jpg)
Other Lab tests
PT - Prothrombin Time Includes INR - International Normalized
Ratio Used to monitor Coumadin therapy PTT - Partial Thromboplastin Time Used to monitor Heparin therapy (not
used with LMWH)
![Page 40: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/40.jpg)
Case Study #2
47yo female admitted with cc of increasing SOB and fatigue. Past medical hx: cardiac arrhythmias, heavy alcohol consumption for many years and 40 pack year smoking history.
![Page 41: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/41.jpg)
Case Study #2
PE: A&O, BP 100/65, HR 96, T 97.5F, RR 23.
Exam of neck showed distended jugular veins. Abdomen: protuberant abdomen with ascites. Liver and spleen not palpable. Pitting edema of LE.
![Page 42: Cardiovascular Laboratory Medicine Brenda Beckett, PA-C.](https://reader030.fdocuments.net/reader030/viewer/2022033103/56649e425503460f94b342b1/html5/thumbnails/42.jpg)
Case Study #2
ECG: Sinus tachycardia and non-specific S-T segment changes.
CXR: No pulmonary infiltrates, no masses. Enlarged heart.
Labs?